Newborn concurrent hearing and genetic screening for hearing impairment: A systematic review and meta‑analysis

Pan,Ke; Shang,Zhirong; Liu,Jialin; Wen,Yidong; Luo,Jing; Zou,Dan; Wang,Aichun; Li,Tao; Liao,Lingyan; Xie,Pan

doi:10.3892/etm.2024.12654

Newborn concurrent hearing and genetic screening for hearing impairment: A systematic review and meta‑analysis

Authors:
- Ke Pan
- Zhirong Shang
- Jialin Liu
- Yidong Wen
- Jing Luo
- Dan Zou
- Aichun Wang
- Tao Li
- Lingyan Liao
- Pan Xie
View Affiliations

Affiliations: Department of Clinical Laboratory, Mianyang Maternity and Child Healthcare Hospital, Mianyang, Sichuan 621000, P.R. China
Published online on: July 16, 2024 https://doi.org/10.3892/etm.2024.12654
Article Number: 365
Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hearing loss is the most prevalent neurosensory disorder in humans, with significant implications for language, social and cognitive development if not diagnosed and treated early. The present systematic review and meta‑analysis aimed to determine the rate of hearing screening pass and genetic screening failure [universal newborn hearing screening (UNHS) pass/genetic failure] and to investigate the advantages of combining newborn hearing and genetic screening for newborn hearing impairment. The PubMed, Embase and Cochrane databases were searched from inception to September 2023 to identify studies reporting the combination of neonatal hearing screening with genetic screening. Duplicate literature, unpublished literature, studies with incomplete data, animal experiments, literature reviews and systematic studies were excluded. All the data were processed by STATA15.1 statistical software. A total of nine cross‑sectional studies were included in this meta‑analysis. The sample sizes ranged from 1,716 to 180,469, and there were a total of 377,688 participants. The pooled results revealed that the prevalence of passing the UNHS while failing genetic screening was 0.31% (95% CI, 0.22‑0.41%). The prevalence of UNHS pass and gap junction protein beta 2 and solute carrier family 26 member 4 variant screen failure was 0.01% (95% CI, 0.00‑0.02%) and 0.00% (95% CI, 0.00%), respectively, while the prevalence of mitochondrially encoded 12S RRNA variant screening failure and UNHS pass was 0.21% (95% CI, 0.18‑0.26%). Combined screening has a significant advantage over pure hearing screening, especially in terms of identifying newborns with mitochondrial gene mutations that render them sensitive to certain medications. In clinical practice, decision‑makers can consider practical circumstances and leverage the benefits of combined newborn hearing and genetic screening for early diagnosis, early counseling, and early intervention in patients with hearing loss.

View Figures

View References

1	Nieman CL and McMahon CM: The World Health Organization's world report on hearing: A call to action for hearing care providers. J Laryngol Otol. 134:377–378. 2020.PubMed/NCBI View Article : Google Scholar
2	Fortnum HM, Summerfield AQ, Marshall DH, Davis AC and Bamford JM: Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: Questionnaire based ascertainment study. BMJ. 323:536–540. 2001.PubMed/NCBI View Article : Google Scholar
3	Kennedy C and McCann D: Universal neonatal hearing screening moving from evidence to practice. Arch Dis Child Fetal Neonatal Ed. 89:F378–F383. 2004.PubMed/NCBI View Article : Google Scholar
4	Tobe RG, Mori R, Huang L, Xu L, Han D and Shibuya K: Cost-effectiveness analysis of a national neonatal hearing screening program in China: Conditions for the scale-up. PLoS One. 8(e51990)2013.PubMed/NCBI View Article : Google Scholar
5	Huang LH, Zhang L, Tobe RY, Qi FH, Sun L, Teng Y, Ke QL, Mai F, Zhang XF, Zhang M, et al: Cost-effectiveness analysis of neonatal hearing screening program in China: Should universal screening be prioritized? BMC Health Serv Res. 12(97)2012.PubMed/NCBI View Article : Google Scholar
6	Young NM, Reilly BK and Burke L: Limitations of universal newborn hearing screening in early identification of pediatric cochlear implant candidates. Arch Otolaryngol Head Neck Surg. 137:230–234. 2011.PubMed/NCBI View Article : Google Scholar
7	Morton CC and Nance WE: Newborn hearing screening-a silent revolution. N Engl J Med. 354:2151–2164. 2006.PubMed/NCBI View Article : Google Scholar
8	Wang Q, Xiang J, Sun J, Yang Y, Guan J, Wang D, Song C, Guo L, Wang H, Chen Y, et al: Nationwide population genetic screening improves outcomes of newborn screening for hearing loss in China. Genet Med. 21:2231–2238. 2019.PubMed/NCBI View Article : Google Scholar
9	Tang X, Liu L, Liang S, Liang M, Liao T, Luo S, Yan T and Chen J: Concurrent newborn hearing and genetic screening in a Multi-ethnic population in South China. Front Pediatr. 9(734300)2021.PubMed/NCBI View Article : Google Scholar
10	Barendregt JJ, Doi SA, Lee YY, Norman RE and Vos T: Meta-analysis of prevalence. J Epidemiol Community Health. 67:974–978. 2013.PubMed/NCBI View Article : Google Scholar
11	Yáñez-Baeza C, Aguilera-Eguía RA, Fuentes-Barría H and Roco-Videla Á: Importance of the PRISMA guideline. Nutr Hosp. 40:670–675. 2023.PubMed/NCBI View Article : Google Scholar : (In Spanish).
12	Zhu QW, Li MT, Zhuang X, Chen K, Xu WQ, Jiang YH and Qin G: Assessment of hearing screening combined with limited and expanded genetic screening for newborns in Nantong, China. JAMA Netw Open. 4(e2125544)2021.PubMed/NCBI View Article : Google Scholar
13	Zeng X, Liu Z, Wang J and Zeng X: Combined hearing screening and genetic screening of deafness among Hakka newborns in China. Int J Pediatr Otorhinolaryngol. 136(110120)2020.PubMed/NCBI View Article : Google Scholar
14	Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997.PubMed/NCBI View Article : Google Scholar
15	Wang QJ, Zhao YL, Rao SQ, Guo YF, He Y, Lan L, Yang WY, Zheng QY, Ruben RJ, Han DY and Shen Y: Newborn hearing concurrent gene screening can improve care for hearing loss: A study on 14,913 Chinese newborns. Int J Pediatr Otorhinolaryngol. 75:535–542. 2011.PubMed/NCBI View Article : Google Scholar
16	Zhang Z, Ding W, Liu X, Xu B, Du W, Nan S and Guo Y: Auditory screening concurrent deafness predisposing genes screening in 10,043 neonates in Gansu province, China. Int J Pediatr Otorhinolaryngol. 76:984–988. 2012.PubMed/NCBI View Article : Google Scholar
17	Zhang J, Wang P, Han B, Ding Y, Pan L, Zou J, Liu H, Pang X, Liu E, Wang H, et al: Newborn hearing concurrent genetic screening for hearing impairment-a clinical practice in 58,397 neonates in Tianjin, China. Int J Pediatr Otorhinolaryngol. 77:1929–1935. 2013.PubMed/NCBI View Article : Google Scholar
18	Peng Q, Huang S, Liang Y, Ma K, Li S, Yang L, Li W, Ma Q, Liu Q, Zhong B and Lu X: Concurrent genetic and standard screening for hearing impairment in 9317 Southern Chinese Newborns. Genet Test Mol Biomarkers. 20:603–608. 2016.PubMed/NCBI View Article : Google Scholar
19	Wu CC, Tsai CH, Hung CC, Lin YH, Lin YH, Huang FL, Tsao PN, Su YN, Lee YL, Hsieh WS and Hsu CJ: Newborn genetic screening for hearing impairment: A population-based longitudinal study. Genet Med. 19:6–12. 2017.PubMed/NCBI View Article : Google Scholar
20	Lu CY, Tsao PN, Ke YY, Lin YH, Lin YH, Hung CC, Su YN, Hsu WC, Hsieh WS, Huang LM, et al: Concurrent hearing, genetic, and cytomegalovirus screening in Newborns, Taiwan. J Pediatr. 199:144–50.e1. 2018.PubMed/NCBI View Article : Google Scholar
21	Dai P, Huang LH, Wang GJ, Gao X, Qu CY, Chen XW, Ma FR, Zhang J, Xing WL, Xi SY, et al: Concurrent hearing and genetic screening of 180,469 neonates with Follow-up in Beijing, China. Am J Hum Genet. 105:803–812. 2019.PubMed/NCBI View Article : Google Scholar
22	Luo H, Yang Y, Wang X, Xu F, Huang C, Liu D, Zhang L, Huang T, Ma P, Lu Q, et al: Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province. Front Pediatr. 10(1020519)2022.PubMed/NCBI View Article : Google Scholar
23	Wen C, Yang X, Cheng X, Zhang W, Li Y, Wang J, Wang C, Ruan Y, Zhao L, Lu H, et al: Optimized concurrent hearing and genetic screening in Beijing, China: A cross-sectional study. Biosci Trends. 17:148–159. 2023.PubMed/NCBI View Article : Google Scholar
24	Wang QJ, Zhao YL, Lan L, Zhao C, Han MK and Han DY: Studies of the strategy for newborn gene screening. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 42:809–813. 2007.PubMed/NCBI(In Chinese).
25	D'Aguillo C, Bressler S, Yan D, Mittal R, Fifer R, Blanton SH and Liu X: Genetic screening as an adjunct to universal newborn hearing screening: Literature review and implications for non-congenital pre-lingual hearing loss. Int J Audiol. 58:834–850. 2019.PubMed/NCBI View Article : Google Scholar
26	Nivoloni Kde A, da Silva-Costa SM, Pomilio MC, Pereira T, Lopes Kde C, de Moraes VC, Alexandrino F, de Oliveira CA and Sartorato EL: Newborn hearing screening and genetic testing in 8974 Brazilian neonates. Int J Pediatr Otorhinolaryngol. 74:926–929. 2010.PubMed/NCBI View Article : Google Scholar
27	Han B, Zong L, Li Q, Zhang Z, Wang D, Lan L, Zhang J, Zhao Y and Wang Q: Newborn genetic screening for high risk deafness-associated mutations with a new Tetra-primer ARMS PCR kit. Int J Pediatr Otorhinolaryngol. 77:1440–1445. 2013.PubMed/NCBI View Article : Google Scholar
28	Guo L, Xiang J, Sun L, Yan X, Yang J, Wu H, Guo K, Peng J, Xie X, Yin Y, et al: Concurrent hearing and genetic screening in a general newborn population. Hum Genet. 139:521–530. 2020.PubMed/NCBI View Article : Google Scholar